$0.4304
-0.26-38.05%
Last update: Nov 5, 3:45 PM
Akebia Therapeutics Inc
AKBANASDAQ
The average analyst price target for Akebia Therapeutics is $4.71, 994.3% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1 to $7.50. The latest change came on Sep 8, 2026, when WestPark Capital initiated coverage of Akebia Therapeutics with a Buy rating and a $4.50 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
